202 related articles for article (PubMed ID: 10479297)
41. Poly(ethylene glycol) prodrugs of the CDK inhibitor, alsterpaullone (NSC 705701): synthesis and pharmacokinetic studies.
Greenwald RB; Zhao H; Xia J; Wu D; Nervi S; Stinson SF; Majerova E; Bramhall C; Zaharevitz DW
Bioconjug Chem; 2004; 15(5):1076-83. PubMed ID: 15366962
[TBL] [Abstract][Full Text] [Related]
42. Aminocarbonyloxymethyl ester prodrugs of flufenamic acid and diclofenac: suppressing the rearrangement pathway in aqueous media.
Ribeiro L; Silva N; Iley J; Rautio J; Järvinen T; Mota-Filipe H; Moreira R; Mendes E
Arch Pharm (Weinheim); 2007 Jan; 340(1):32-40. PubMed ID: 17206608
[TBL] [Abstract][Full Text] [Related]
43. Enzymatic activation of second-generation dendritic prodrugs: Conjugation of self-immolative dendrimers with poly(ethylene glycol) via click chemistry.
Gopin A; Ebner S; Attali B; Shabat D
Bioconjug Chem; 2006; 17(6):1432-40. PubMed ID: 17105221
[TBL] [Abstract][Full Text] [Related]
44. Bystander killing of tumour cells by antibody-targeted enzymatic activation of a glucuronide prodrug.
Cheng TL; Wei SL; Chen BM; Chern JW; Wu MF; Liu PW; Roffler SR
Br J Cancer; 1999 Mar; 79(9-10):1378-85. PubMed ID: 10188879
[TBL] [Abstract][Full Text] [Related]
45. Self-immolative anthracycline prodrugs for suicide gene therapy.
Niculescu-Duvaz I; Niculescu-Duvaz D; Friedlos F; Spooner R; Martin J; Marais R; Springer CJ
J Med Chem; 1999 Jul; 42(13):2485-9. PubMed ID: 10395490
[TBL] [Abstract][Full Text] [Related]
46. Synthesis, stability and in vitro dermal evaluation of aminocarbonyloxymethyl esters as prodrugs of carboxylic acid agents.
Mendes E; Furtado T; Neres J; Iley J; Jarvinen T; Rautio J; Moreira R
Bioorg Med Chem; 2002 Mar; 10(3):809-16. PubMed ID: 11814870
[TBL] [Abstract][Full Text] [Related]
47. Tripartate poly(ethylene glycol) prodrugs of the open lactone form of camptothecin.
Greenwald RB; Zhao H; Xia J
Bioorg Med Chem; 2003 Jun; 11(12):2635-9. PubMed ID: 12757729
[TBL] [Abstract][Full Text] [Related]
48. Circulating half-life of PEGylated recombinant methioninase holoenzyme is highly dose dependent on cofactor pyridoxal-5'-phosphate.
Yang Z; Sun X; Li S; Tan Y; Wang X; Zhang N; Yagi S; Takakura T; Kobayashi Y; Takimoto A; Yoshioka T; Suginaka A; Frenkel EP; Hoffman RM
Cancer Res; 2004 Aug; 64(16):5775-8. PubMed ID: 15313919
[TBL] [Abstract][Full Text] [Related]
49. Enzymatic release of antitumor ether lipids by specific phospholipase A2 activation of liposome-forming prodrugs.
Andresen TL; Davidsen J; Begtrup M; Mouritsen OG; Jørgensen K
J Med Chem; 2004 Mar; 47(7):1694-703. PubMed ID: 15027860
[TBL] [Abstract][Full Text] [Related]
50. A carbamate-based approach to primaquine prodrugs: antimalarial activity, chemical stability and enzymatic activation.
Mata G; do Rosário VE; Iley J; Constantino L; Moreira R
Bioorg Med Chem; 2012 Jan; 20(2):886-92. PubMed ID: 22189276
[TBL] [Abstract][Full Text] [Related]
51. Polyacetal and poly(ortho ester)-poly(ethylene glycol) graft copolymer thermogels: preparation, hydrolysis and FITC-BSA release studies.
Schacht E; Toncheva V; Vandertaelen K; Heller J
J Control Release; 2006 Nov; 116(2):219-25. PubMed ID: 16962198
[TBL] [Abstract][Full Text] [Related]
52. In vitro and in vivo study of poly(ethylene glycol) conjugated ketoprofen to extend the duration of action.
Choi HK; Chun MK; Lee SH; Jang MH; Kim HD; Jung CS; Oh SY
Int J Pharm; 2007 Aug; 341(1-2):50-7. PubMed ID: 17517483
[TBL] [Abstract][Full Text] [Related]
53. (Acyloxy)alkyl carbamates as novel bioreversible prodrugs for amines: increased permeation through biological membranes.
Alexander J; Cargill R; Michelson SR; Schwam H
J Med Chem; 1988 Feb; 31(2):318-22. PubMed ID: 2892933
[TBL] [Abstract][Full Text] [Related]
54. Hapten-directed targeting to single-chain antibody receptors.
Cheng TL; Liao KW; Tzou SC; Cheng CM; Chen BM; Roffler SR
Cancer Gene Ther; 2004 May; 11(5):380-8. PubMed ID: 15044963
[TBL] [Abstract][Full Text] [Related]
55. Isophosphoramide mustard analogues as prodrugs for anticancer gene-directed enzyme-prodrug therapy (GDEPT).
Misiura K; Szymanowicz D; Kuśnierczyk H; Wietrzyk J; Opolski A
Acta Biochim Pol; 2002; 49(1):169-76. PubMed ID: 12136937
[TBL] [Abstract][Full Text] [Related]
56. N-Substituted 2-(2,6-dinitrophenylamino)propanamides: novel prodrugs that release a primary amine via nitroreduction and intramolecular cyclization.
Sykes BM; Atwell GJ; Hogg A; Wilson WR; O'Connor CJ; Denny WA
J Med Chem; 1999 Feb; 42(3):346-55. PubMed ID: 9986704
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of polyethylene glycol-conjugated novel polymeric anti-tumor drug for cancer therapy.
Nam JP; Park JK; Son DH; Kim TH; Park SJ; Park SC; Choi C; Jang MK; Nah JW
Colloids Surf B Biointerfaces; 2014 Aug; 120():168-75. PubMed ID: 24918700
[TBL] [Abstract][Full Text] [Related]
58. Novel prodrug approach for tertiary amines: synthesis and preliminary evaluation of N-phosphonooxymethyl prodrugs.
Krise JP; Zygmunt J; Georg GI; Stella VJ
J Med Chem; 1999 Aug; 42(16):3094-100. PubMed ID: 10447953
[TBL] [Abstract][Full Text] [Related]
59. Elongated multiple electronic cascade and cyclization spacer systems in activatible anticancer prodrugs for enhanced drug release.
de Groot FM; Loos WJ; Koekkoek R; van Berkom LW; Busscher GF; Seelen AE; Albrecht C; de Bruijn P; Scheeren HW
J Org Chem; 2001 Dec; 66(26):8815-30. PubMed ID: 11749612
[TBL] [Abstract][Full Text] [Related]
60. Carbamate ester prodrugs of dopaminergic compounds: synthesis, stability, and bioconversion.
Hansen KT; Faarup P; Bundgaard H
J Pharm Sci; 1991 Aug; 80(8):793-8. PubMed ID: 1686464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
